M11-290
ClinicalTrials.gov NCT02065557
Research payments
$50,438
Through program year 2020, $50,438 in research payments was reported against M11-290, across 50 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02065557
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $438 | 3 |
| 2019 | Research | $50,001 | 47 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ramalingam Arumugam Saint Paul, MN Named on 7 payments
- Ashwin Ananthakrishnan Boston, MA Named on 7 payments
- Joel Rosh Morristown, NJ Named on 5 payments
- Amy Devlin Boston, MA Named on 5 payments
- Jeffrey Bornstein Orlando, FL Named on 4 payments
- Blair Lewis New York, NY Named on 4 payments
- Melvin Heyman San Francisco, CA Named on 4 payments
- William Faubion Rochester, MN Named on 4 payments
- Melawati Yuwono Tacoma, WA Named on 3 payments
- Marian Pfefferkorn Indianapolis, IN Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.